维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="J.Sandborn"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Autoimmune disorders and extraintestinal manifestations in first‐degree familial and sporadic inflammatory bowel disease. A case–control study显示文摘	ElenaRicart RemoPanaccione Edward V.Loftus William J.Tremaine W. ScottHarmsen Alan R.Zinsmeister William J.Sandborn	2006	Inflamm Bowel Dis2006，，3：	3
	2	Long‐term infliximab maintenance therapy for ulcerative colitis: The ACT‐1 and ‐2 extension studies显示文摘	WalterReinisch William J.Sandborn PaulRutgeerts Brian G.Feagan DanielRachmilewitz Stephen B.Hanauer Gary R.Lichtenstein Willem J.S.de Villiers MarionBlank YinghuaLang JewelJohanns Jean FrédéricColombel DanielPresent Bruce E.Sands	2012	Inflamm Bowel Dis2012，，2：	3
	3	A simple classification of Crohn’s disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998显示文摘	ChristophGasche JurgenScholmerich JornBrynskov GeertD’Haens Stephen B.Hanauer E. JanIrvine Derek P.Jewell DanielRachmilewitz David B.Sachar William J.Sandborn Lloyd R.Sutherland	2007	Inflamm Bowel Dis2007，，1：	2
	4	The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro‐drugs used in the management of ulcerative colitis显示文摘	W. J.Sandborn S. B.Hanauer	2002	Alimentary Pharmacology & Therapeutics2002，，1：	1
	5	Adalimumab sustains clinical remission and overall clinical benefit after 2?years of therapy for Crohn’s disease显示文摘	R.PANACCIONE J.‐F.COLOMBEL W. J.SANDBORN P.RUTGEERTS G. R.D’HAENS A. M.ROBINSON J.CHAO P. M.MULANI P. F.POLLACK	2010	Alimentary Pharmacology & Therapeutics2010，，12：	1
	6	Symptomatic overlap between irritable bowel syndrome and microscopic colitis显示文摘	DavidLimsui Darrell S.Pardi MichaelCamilleri Edward V.Loftus Jr. Patricia P.Kammer William J.Tremaine William J.Sandborn	2007	Inflamm Bowel Dis2007，，2：	1
	7	Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn’s disease显示文摘	S. B.Hanauer J.Panes J.‐F.Colombel R.Bloomfield S.Schreiber W. J.Sandborn	2010	Alimentary Pharmacology & Therapeutics2010，，3：	1
	8	Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety显示文摘	William J.Sandborn Stephen B.Hanauer	2007	Inflamm Bowel Dis2007，，：	1
	9	Indeterminate colitis: A review of the concept — What’s in a name?显示文摘	KarelGeboes Jean‐FrédéricColombel AdrianGreenstein Derek P.Jewell William J.Sandborn Morten H.Vatn BryanWarren Robert H.Riddell	2008	Inflamm Bowel Dis2008，，6：	1
	10	Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease显示文摘	R.PANACCIONE P.RUTGEERTS W. J.SANDBORN B.FEAGAN S.SCHREIBER S.GHOSH	2008	Alimentary Pharmacology & Therapeutics2008，，6：	1
	11	Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease – subgroup results from a placebo‐controlled study显示文摘	S.Schreiber I. C.Lawrance O. ?.Thomsen S. B.Hanauer R.Bloomfield W. J.Sandborn	2010	Alimentary Pharmacology & Therapeutics2010，，2：	1
	12	MMX Multi Matrix System^? mesalazine for the induction of remission in patients with mild‐to‐moderate ulcerative colitis: a combined analysis of two randomized, double‐blind, placebo‐controlled trials显示文摘	W. J.SANDBORN M. A.KAMM G. R.LICHTENSTEIN A.LYNE T.BUTLER R. E.JOSEPH	2007	Alimentary Pharmacology & Therapeutics2007，，：	1
	13	Epidemiology of inflammatory bowel disease in Asia显示文摘	Suk‐KyunYang Edward V.Loftus William J.Sandborn	2006	Inflamm Bowel Dis2006，，3：	1
	14	Outcome of sporadic adenomas and adenoma‐like dysplasia in patients with ulcerative colitis undergoing polypectomy显示文摘	John B.Kisiel Edward V.Loftus W. ScottHarmsen Alan R.Zinsmeister William J.Sandborn	2012	Inflamm Bowel Dis2012，，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费